Radial Reload Laparoscopic LAR Case Series
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01706822 |
|
Recruitment Status :
Terminated
(Slow recruitment)
First Posted : October 15, 2012
Results First Posted : March 18, 2015
Last Update Posted : March 18, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Colorectal Cancer | Device: Covidien Radial Reload Stapler with Tri-Staple Technology | Phase 4 |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 8 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Treatment |
| Official Title: | Evaluating the Radial Reload Stapler With Tri-Staple TM Technology During Laparoscopic Low Anterior Resection for Rectal Cancer: A Prospective Multicenter Case Series |
| Study Start Date : | April 2013 |
| Actual Primary Completion Date : | November 2013 |
| Actual Study Completion Date : | November 2013 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Covidien Radial Reload Stapler with Tri-Staple Technology
Covidien Radial Reload Stapler with Tri-Staple Technology in laparoscopic LAR or proctosigmoidectomy
|
Device: Covidien Radial Reload Stapler with Tri-Staple Technology
Case series of patients arlaedy selected to undergo a laparoscopic LAR using the Radial Reload stapler |
- The Surgeon's Ability to Achieve a Staple Line at the Desired Level of the Rectum. The Reported Value Represents the Number of Participants in Whom the Criteria Was Met [ Time Frame: Operative ]The surgeon's ability to achieve a staple line at the desired level of the rectum.
- The Ability to Achieve Adequate Distal Margins (Defined as >2cm [or >1cm With Clear Histologic Evaluation]) in the Low Rectum. The Reported Value Represents the Number of Participants in Whom the Criteria Was Met [ Time Frame: Operative ]The ability to achieve adequate distal margins (defined as >2cm [or >1cm with clear histologic evaluation]) in the low rectum.
- Access Measured by Surgeon Usability Questionnaire. The Reported Values Represent Percentage of Cases Surgeon Agree/Strongly Agree [ Time Frame: Operatively ]1. Access measured by surgeon usability questionnaire.
- Visibility Measured by Surgeon Usability Questionnaire. The Reported Values Represent Percentage of Cases Surgeon Agree/Strongly Agree [ Time Frame: Operatively ]2. Visibility measured by surgeon usability questionnaire
- Maneuverability Measured by Surgeon Usability Questionnaire. The Reported Values Represent Percentage of Cases Surgeon Agree/Strongly Agree [ Time Frame: Operatively ]3. Maneuverability measured by surgeon usability questionnaire Question: Maneuverability of Radial reload during the procedure was adequate
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 85 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The subject is able to understand and sign Informed Consent Form.
- The subject is between 18-85 years of age.
- The subject is anticipated to undergo a resection of the rectum with anastomosis below the peritoneal reflection.
- The subject is anticipated to undergo mobilization and stapling of the rectum laparoscopically.
Exclusion Criteria:
- Any female patient, who is pregnant, suspected pregnant, or nursing.
- The participant is unable or unwilling to comply with the study requirements, follow-up schedule.
- The participant has co-morbidities which, in the opinion of the investigator, will not be appropriate for the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01706822
| United States, Ohio | |
| University Hospitals Case Medical Center | |
| Cleveland, Ohio, United States, 44106 | |
| Principal Investigator: | Conor Delaney, MD | University Hospitals Cleveland Medical Center |
| Responsible Party: | Medtronic - MITG |
| ClinicalTrials.gov Identifier: | NCT01706822 |
| Other Study ID Numbers: |
COVLARL0287 |
| First Posted: | October 15, 2012 Key Record Dates |
| Results First Posted: | March 18, 2015 |
| Last Update Posted: | March 18, 2015 |
| Last Verified: | March 2015 |
|
Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site Neoplasms |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |

